References
- CardozoLDrutzHPBayganiSKPharmacological treatment of women awaiting surgery for stress urinary incontinenceAm Coll Obstet Gynecol200410451119
- DmochowskiRRMiklosJRNortonPADuloxetine versus placebo for the treatment of North American women with stress urinary incontinenceJ Urol200317012596314501737
- DownieJEspeyMGajewskiJAlpha 2-adrenoceptors not imidazole receptors mediate depression of a sacral spinal reflex in the catEur J Pharmacol199119530141678710
- DurantPLucasPYakshTMicturition in the unanesthetized rat: spinal vs. peripheral pharmacology of the adrenergic systemJ Pharmacol Exp Ther1988245426353367300
- Eli Lilly NederlandBVYentreve: summary of product characteristics [online]2004 Accessed 11 Oct 2004 URL: http://www.emea.eu.int/humandocs/Humans/EPAR/yentrve/yentreve.htm
- GhoniemGMVan LeeuwnJSElserDMA randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment, and no active treatment in women with stress urinary incontinenceJ Urol20051731453415821458
- GoldsteinDJLuYDetkeMJDuloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetineJ Clin Psychopharmacol2004243899915232330
- GoldsteinDJLuYDetkeMJDuloxetine vs placebo in patients with painful diabetic neuropathyPain20051161091815927394
- GoldsteinDJMallinckrodtCLuYDuloxetine in the treatment of major depression disorder: a double-blind clinical trialJ Clin Psychiatry2002632253111926722
- HampelCWienholdDBenkenNPrevalence and natural history of female incontinenceEur Urol199732Suppl 23129248806
- HosoyaYOkadoNSuiuraYKohnoKCoincidence of “ladder-like patterns” in distributions of monoaminergic terminals and sympathetic preganglionic neurons in the rat spinal cordExp Brain Res19918622481756794
- IshigookaJNagataETakahashiASimultaneous monitoring of inhibition of serotonin uptake by platelets and plasma concentration following administration of duloxetine, a new antidepressant candidate, to healthy volunteersCurr Ther Res19975867992
- JostWHNeurologie des Beckenbodens1997London, Glasgow, WeinheimChapman & Hall
- KarlKBKatofiascMAEffects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female catJ Pharmacol Exp Ther19952741014247636716
- KatofiascMANissenJAudiaJEComparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in catsLife Sci20027112273612106588
- LantzRJGillespieTARashTJMetabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjectsDrug Metab Dispos20033111425012920170
- MichelMCPetersSLRole of serotonin and noradrenaline in stress urinary incontinenceBJU Int200494Suppl I233015139860
- MillardRJMooreKRenckenRDuloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trialBJU Int2004933111814764128
- NortonPZinnerNYalcinIBumpRDuloxetine versus placebo in the treatment of stress urinary incontinenceAm J Obstet Gynecol200218740812114886
- OnufrowiczBNotes on the arrangement and function of the cell groups of the sacral region of the spinal cordJ Nerv Men Dis188926498504
- OnufrowiczBOn the arrangement and function of the cell groups of the sacral region of the sacral spinal cord in manArch Neurol Psychopathol18903387411
- SharmaAGoldbergMJCerimeleBJPharmacokinetics and safety of duloxetine, a dual serotonin and norepinephrine reuptake inhibitorJ Clin Pharmacol200040161710664922
- SkinnerMHKuanHYSkerjanecAEffect of age on the pharmacokinetics of duloxetine in womenBr J Clin Pharmacol200457546114678340
- ThorKSerotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: Implication for treating stress urinary incontinenceUrology200362Suppl 4A3914550831
- van KerrebroeckPAbramsPLangeRDuloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinenceB J Obstet Gynaecol200411124957
- WongDBymasterFMayleDLY 2486 8, a new inhibitor of serotonin and norepinephrine uptakeNeuropsychopharmacology1993823338424846